Mononucleosis is a contagious disease that is most often caused by the Epstein-Barr virus (EBV). Symptoms can include fatigue, fever, rash, sore throat, aches and pains, and swollen lymph nodes, liver and spleen. Unfortunately, the disease takes a while to kick–while some patient improve within a couple of weeks, symptoms have been known to last for more than six months. But fortunately, researchers are optimistic that a vaccine for EBV could be on the horizon.
In laboratory studies, a new nanoparticle-based vaccine has been shown to protect mice and monkeys against EBV. Initial results look promising, and as Epstein-Barr has also been linked to about 200,000 different types of cancer, the implications could be much bigger than just the development of a vaccine to protect against mono.
Pretty exciting. Hopefully, research continues to progress and the vaccine will prove to be a success in human patients. Read more about this research here.